Filter
2506
Filtered Results: 2506
Text search:
drug
trial
Featured
Recommendations
231
New Publications
500
Language
Document type
No document type
1498
Guidelines
387
Studies & Reports
376
Manuals
100
Strategic & Response Plan
52
Fact sheets
40
Training Material
22
Situation Updates
13
Infographics
8
Resource Platforms
6
Brochures
3
App
1
Countries / Regions
India
145
Global
87
South Africa
63
Western and Central Europe
55
Kenya
43
Nigeria
39
Ethiopia
38
Africa
37
Uganda
36
Eastern Europe
29
Liberia
29
Zambia
28
Malawi
27
Tanzania
27
Nepal
26
Sierra Leone
26
Russia
26
Ukraine
25
Ghana
21
Zimbabwe
20
Latin America and the Carribbean
20
Rwanda
19
Asia
18
Philippines
17
Bangladesh
17
Myanmar / Burma
16
South–East Asia Region
15
Brazil
14
East and Southern Africa
13
Namibia
13
Colombia
11
Lesotho
11
Mozambique
11
Cambodia
11
West and Central Africa
11
Germany
10
USA
9
Middle East and North Africa
9
South Sudan
9
Indonesia
9
Congo, Democratic Republic of
7
Botswana
7
Eswatini/ Swaziland
7
Tajikistan
6
Thailand
6
Syria
6
Cameroon
5
Albania
5
Senegal
5
Guinea
5
Eastern Europe and Central Asia
5
Laos
4
Burkina Faso
4
Venezuela
4
Argentina
4
Vietnam
4
Papua New Guinea
4
Sudan
4
Georgia
4
China
3
Haiti
3
Paraguay
3
Spain
3
Lebanon
3
Yemen
3
Central African Republic
3
Angola
3
Pakistan
3
North Macedonia
2
Mexico
2
Benin
2
Iran
2
Estonia
2
Kyrgyzstan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Jordan
2
Jamaica
2
United Kingdom
2
Portugal
2
Belarus
2
Southern Africa
2
Bolivia
2
Sri Lanka
2
Poland
2
Iraq
2
Turkey
1
Gambia
1
Kazakhstan
1
Singapore
1
Peru
1
Qatar
1
Bulgaria
1
Armenia
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Denmark
1
Belgium
1
France
1
Tunisia
1
Norway
1
Côte d’Ivoire / Ivory Coast
1
Greece
1
Mali
1
Bhutan
1
Somalia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
685
Clinical Guidelines
336
Public Health
138
Women & Child Health
100
Pharmacy & Technologies
29
Key Resources
24
Capacity Building
19
Toolboxes
HIV
344
Mental Health
339
TB
298
COVID-19
162
NTDs
116
AMR
89
NCDs
77
Pharmacy
72
Ebola
57
Rapid Response
34
Caregiver
30
Refugee
28
Planetary Health
25
Disability
24
Global Health Education
16
Conflict
14
Health Financing Toolbox
12
Polio
9
Social Ethics
7
Specific Hazards
5
Natural Hazards
5
Cholera
5
Zika
3
Health Financing
1
Nature, vol.513 (4 September 2014) 13-14
Soil-transmitted helminths (STH) affect 1.45 billion people worldwide, and high intensity infections are associated with anemia, undernutrition and impaired cognition, particularly among children. Mathematical models suggest it may be possible to interrupt the transmission of STH in a community by e...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
Background
The core clinical symptoms of addiction include an enhanced incentive for drug taking (craving), impaired self-control (impulsivity and compulsivity), emotional dysregulation (negative mood) and increased stress reactivity. Symptoms related to impaired self-control involve reduced activi...
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical trials have recently shown...
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
DOI: 10.5772/intechopen.102891Little progress has been made since the 1960s and 19. 70s to widen the therapeutic arsenal against Trypanosoma cruzi, the causative pathogen of Chagas disease, which remains a frustrating and perplexing infectious disease. This chapter focuses on the strategic and opera...
The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public health problem throughout Latin America. Current therapeutic options are characterised by limited efficacy, long treatment regimens and frequent toxic side-effects. Advances in this area have been compromised by gaps...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
The pharmacological treatment of heart failure has evolved over the last three decades since the demonstration of the effect of angiotensinconverting enzyme inhibitors on major cardiovascular events in patients with heart failure with reduced ejection fraction. Composite analysis of heart failure wi...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
Phillips and colleagues have shown that rifampicin combined with clarithromycin is non-inferior to RS8, and is safer. This much anticipated trial provides us with a high degree of confidence that an 8-week course of oral rifampicin and clarithromycin should now be the cornerstone of the treatment of...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie...
The Lancet olume 395, ISSUE 10232, P1259-1267, April 18, 2020. Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifa...
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
